Return
CSF1R INHIBITION RETARDS MESOTHELIOMA PROGRESSION AND AMPLIFIES CHECKPOINT THERAPY
DOI:10.1016/j.chest.2019.04.049.png)
Abstract
En
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

